Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection.

The efficacy of oral WIN 54954 for the prevention of rhinovirus infection and illness was tested in two randomized, double-blinded, placebo-controlled volunteer challenge studies. Volunteers were inoculated with rhinovirus type 39 (MIC of WIN 54954, 0.17 microgram/ml) or rhinovirus type 23 (MIC, 0.0...

Full beskrivning

Bibliografiska uppgifter

I publikationen:	Antimicrob Agents Chemother
Huvudupphov:	Turner, R B, Dutko, F J, Goldstein, N H, Lockwood, G, Hayden, F G
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	American Society for Microbiology (ASM) 1993
Ämnen:	Research Article
Länkar:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187656/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8383943/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.2.297
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!